Status:
COMPLETED
Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu
Lead Sponsor:
PowderMed
Conditions:
Influenza (Pandemic)
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate how well the vaccine is tolerated at sites where administrations are given, any effects it may have on subjects' wellbeing and whether it can produce antibody ...
Detailed Description
Pandemic influenza occurs when a strain of influenza to which the human population has not been exposed develops the ability to infect man and spread from person to person. Some pandemics can have ver...
Eligibility Criteria
Inclusion
- Healthy adults volunteers (women must be of nonchild-bearing potential) Provided written informed consent
- \-
Exclusion
- No significant concomitant illness No allergy to gold No immunosuppression due to disease or treatment
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00347529
Start Date
August 1 2006
End Date
January 1 2007
Last Update
January 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guys Research Drug Unit, Quintiles Ltd.
London, United Kingdom, SE1 1YR